Published in J Clin Psychiatry on May 01, 2003
Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull (2007) 2.00
Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophr Bull (2007) 1.09
Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment. Schizophr Bull (2006) 1.06
Very poor outcome schizophrenia: clinical and neuroimaging aspects. Int Rev Psychiatry (2007) 1.04
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Quality of life in schizophrenic patients. Dialogues Clin Neurosci (2007) 0.96
Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology (2011) 0.95
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.92
Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatr Dis Treat (2007) 0.87
The impact of skills training on cognitive functioning in older people with serious mental illness. Am J Geriatr Psychiatry (2013) 0.87
Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function. Schizophr Bull (2007) 0.86
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci (2007) 0.84
Driving simulator performance and psychomotor functions of schizophrenic patients treated with antipsychotics. Eur Arch Psychiatry Clin Neurosci (2009) 0.81
Bipolar disorders: treatment options and patient satisfaction. Neuropsychiatr Dis Treat (2006) 0.75
Are second generation antipsychotics a distinct class? J Psychiatr Pract (2008) 0.75
Driving skills in unmedicated first- and recurrent-episode schizophrenic patients. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry (2007) 2.68
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res (2004) 2.15
Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv (2007) 1.99
Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull (2006) 1.75
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry (2004) 1.75
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry (2007) 1.73
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull (2007) 1.72
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res (2007) 1.66
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry (2003) 1.56
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disord (2011) 1.50
Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer (2005) 1.45
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). Psychiatry Res (2007) 1.45
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. Antimicrob Agents Chemother (2010) 1.45
Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Endocr Relat Cancer (2005) 1.43
Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord (2006) 1.41
Osteoblastoma of the maxilla and mandible: a report of 24 cases, review of the literature, and discussion of its relationship to osteoid osteoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.41
Late relapse/sustained abstinence among former smokers: a longitudinal study. Prev Med (2004) 1.40
A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer (2011) 1.36
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model (2008) 1.35
Diabetic eNOS knockout mice develop distinct macro- and microvascular complications. Lab Invest (2008) 1.32
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med (2012) 1.30
Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med (2008) 1.24
Results of phase 3 of the CATIE schizophrenia trial. Schizophr Res (2008) 1.23
A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophr Bull (2002) 1.20
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res (2009) 1.20
Induction of adaptive response in human blood lymphocytes exposed to radiofrequency radiation. Radiat Res (2009) 1.18
Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. J Clin Oncol (2006) 1.18
Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv (2003) 1.17
Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat (2008) 1.14
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology (2007) 1.13
Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res (2009) 1.13
Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia. Schizophr Res (2008) 1.12
Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials. J Clin Microbiol (2010) 1.11
Unforeseen inpatient mortality among veterans with schizophrenia. Med Care (2006) 1.09
How the relationship of attitudes toward mental health treatment and service use differs by age, gender, ethnicity/race and education. Soc Psychiatry Psychiatr Epidemiol (2009) 1.07
A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia. Schizophr Bull (2012) 1.07
Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Res (2002) 1.06
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr Serv (2006) 1.05
Trail making test errors and executive function in schizophrenia and depression. Clin Neuropsychol (2006) 1.03
Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol (2004) 1.02
Barriers to, and strategies for, starting a long acting injection clinic in a community mental health center. Community Ment Health J (2011) 1.01
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry (2003) 0.99
Induction of adaptive response in human blood lymphocytes exposed to 900 MHz radiofrequency fields: influence of cell cycle. Int J Radiat Biol (2011) 0.98
Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology (2011) 0.98
Deconstructing processing speed deficits in schizophrenia: application of a parametric digit symbol coding test. Schizophr Res (2010) 0.95
LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Adv Ther (2008) 0.93
A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophr Res (2004) 0.93
Real-world antipsychotic treatment practices. Psychiatr Clin North Am (2007) 0.93
The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull (2002) 0.92
Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy (2005) 0.92
Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res (2002) 0.92
Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application. J Invest Dermatol (2003) 0.91
Diabetes and risk of renal cell carcinoma. J Cancer (2011) 0.91
Risk factors for the development of hypothyroidism after hemithyroidectomy. Arch Otolaryngol Head Neck Surg (2006) 0.91
Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology (2010) 0.90
Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability. Int J Methods Psychiatr Res (2008) 0.89
Genetic damage in human cells exposed to non-ionizing radiofrequency fields: a meta-analysis of the data from 88 publications (1990-2011). Mutat Res (2012) 0.89
Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Med Hypotheses (2008) 0.89
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med (2005) 0.89
Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Adm Policy Ment Health (2011) 0.88
Accuracy of cone beam computed tomography in determining the location of the genial tubercle. Otolaryngol Head Neck Surg (2007) 0.87
Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder. Am J Public Health (2009) 0.86
Genetic damage in mammalian somatic cells exposed to extremely low frequency electro-magnetic fields: a meta-analysis of data from 87 publications (1990-2007). Int J Radiat Biol (2009) 0.85
The mental health treatment study. Psychiatr Rehabil J (2008) 0.85
IkappaBalpha-dependent regulation of low-shear flow-induced NF-kappa B activity: role of nitric oxide. Am J Physiol Cell Physiol (2003) 0.85
Age-related instability in spermatogenic cell nuclear and mitochondrial DNA obtained from Apex1 heterozygous mice. Mol Reprod Dev (2011) 0.85
Genetic damage in mammalian somatic cells exposed to radiofrequency radiation: a meta-analysis of data from 63 publications (1990-2005). Radiat Res (2008) 0.84
Micronuclei in peripheral blood and bone marrow cells of mice exposed to 42 GHz electromagnetic millimeter waves. Radiat Res (2004) 0.84
Patient assessment of tests to detect cervical cancer. Int J Technol Assess Health Care (2007) 0.83
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence. PLoS One (2012) 0.83
An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. Psychiatr Serv (2006) 0.83
Implementation of the Texas Medication Algorithm Project patient and family education program. J Clin Psychiatry (2006) 0.81
Prediabetes assessment and follow-up in older veterans with schizophrenia. Am J Geriatr Psychiatry (2010) 0.81
Catching up on health outcomes: the Texas Medication Algorithm Project. Health Serv Res (2003) 0.81
Diagnostic efficacy of additional step-sections in colorectal biopsies originally diagnosed as normal. Hum Pathol (2008) 0.81
A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio. Psychiatr Serv (2003) 0.80
Banking on Fatherhood: pilot studies of a computerized educational tool on sperm banking before cancer treatment. Psychooncology (2009) 0.80
Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia. Psychiatr Serv (2011) 0.80
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers. J Antimicrob Chemother (2013) 0.80
Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels. Ear Nose Throat J (2010) 0.79
Adrenal metastectomy is safe in selected patients. World J Surg (2014) 0.79
Pathologic changes in breast cancer after anti-estrogen therapy. Breast J (2012) 0.79
The art and science of switching antipsychotic medications, part 2. J Clin Psychiatry (2007) 0.78
The short-term impact of generic versus individualized environmental supports on functional outcomes and target behaviors in schizophrenia. Psychiatry Res (2009) 0.78
The H-Wave device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Adv Ther (2008) 0.78
The relationship between blood IL-12p40 level and melanoma progression. Int J Cancer (2014) 0.78
Prescriber fidelity to a medication management evidence-based practice in the treatment of schizophrenia. Psychiatr Serv (2009) 0.78
Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study. Psychiatr Serv (2013) 0.77
Incidence of micronuclei in human peripheral blood lymphocytes exposed to modulated and unmodulated 2450 MHz radiofrequency fields. Bioelectromagnetics (2013) 0.77